Skip to main content
HR 8663 118th Congress House Science, Technology, Communications Advanced technology and technological innovations Computers and information technology Drug trafficking and controlled substances Libraries and archives Research and development

DETECT Fentanyl and Xylazine Act of 2024

Introduced: June 7, 2024 Introduced by: LaLota, Nick Republican · New York See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 29 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 23, 2024
Became Public Law No: 118-186.
Dec 23, 2024
Signed by President.
Dec 23, 2024
Presented to President.
Dec 18, 2024
Motion to reconsider laid on the table Agreed to without objection.
Dec 18, 2024
On motion that the House suspend the rules and agree to the Senate amendments Agreed to by the Yeas and Nays: (2/3 required): 404 - 1 (Roll no. 514). (text: CR H7335-7336)
Dec 18, 2024
Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendments Agreed to by the Yeas and Nays: (2/3 required): 404 - 1 (Roll no. 514). (text: CR H7335-7336)
Dec 18, 2024
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.
Dec 18, 2024
DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and agree to the Senate amendments to H.R. 8663.
Dec 18, 2024
Mr. Green (TN) moved that the House suspend the rules and agree to the Senate amendments. (consideration: CR H7335-7337, H7340-7341)
Dec 13, 2024
Message on Senate action sent to the House.
Dec 12, 2024
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7041)
Dec 12, 2024
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.
Dec 12, 2024
Measure laid before Senate by unanimous consent. (consideration: CR S7041)
Dec 12, 2024
Senate Committee on Homeland Security and Governmental Affairs discharged by Unanimous Consent.
Sep 10, 2024
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Sep 9, 2024
Motion to reconsider laid on the table Agreed to without objection.
Sep 9, 2024
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5064)
Sep 9, 2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5064)
Sep 9, 2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 8663.
Sep 9, 2024
Considered under suspension of the rules. (consideration: CR H5064-5065)
Sep 9, 2024
Mr. Gimenez moved to suspend the rules and pass the bill.
Aug 23, 2024
Placed on the Union Calendar, Calendar No. 531.
Aug 23, 2024
Reported by the Committee on Homeland Security. H. Rept. 118-634.
Jun 12, 2024
Ordered to be Reported by Voice Vote.
Jun 12, 2024
Committee Consideration and Mark-up Session Held
Jun 12, 2024
Subcommittee on Emergency Management and Technology Discharged
Jun 7, 2024
Referred to the Subcommittee on Emergency Management and Technology.
Jun 7, 2024
Referred to the House Committee on Homeland Security.
Jun 7, 2024
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Dec 18, 2024 House · vote #514 On Motion to Suspend the Rules and Concur in the Senate Amendments Passed 404–1 See who voted →
 Plain-English summary Congressional Research Service

Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024

This act provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine.

Specifically, the act provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The act additionally requires the directorate to follow certain standards and rely on certain information from the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.

What's happening now December 23, 2024

Became Public Law No: 118-186.

 Committees of jurisdiction 3
 Cosponsors 2
All 2 Democratic 2